sedative dosages of the benzodiazepine , diazepam ( 76 micro mol/kg , i.p . ) , reduce the light-evoked increase in retinal dopamine turnover , while intraocular applications of the water-soluble benzodiazepine , flurazepam ( 0.50 or 1.0 micro mol/eyeball ) , produce a dose-dependent suppression of light-enhanced dopamine synthesis .
C0005064
benzodiazepine
C0016375
flurazepam